0001209191-17-045911.txt : 20170721 0001209191-17-045911.hdr.sgml : 20170721 20170721160105 ACCESSION NUMBER: 0001209191-17-045911 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170720 FILED AS OF DATE: 20170721 DATE AS OF CHANGE: 20170721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stein Steven H CENTRAL INDEX KEY: 0001673776 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 17976611 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-20 0 0000879169 INCYTE CORP INCY 0001673776 Stein Steven H 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 EVP & Chief Medical Officer Common Stock 2017-07-20 4 M 0 1191 88.68 A 19356 D Common Stock 2017-07-20 4 M 0 4772 83.83 A 24128 D Common Stock 2017-07-20 4 M 0 522 95.76 A 24650 D Common Stock 2017-07-20 4 S 0 1191 131.09 D 23459 D Common Stock 2017-07-20 4 S 0 4772 131.09 D 18687 D Common Stock 2017-07-20 4 S 0 522 131.09 D 18165 D Non-Qualified Stock Option (right to buy) 88.68 2017-07-20 4 M 0 1191 0.00 D 2022-03-01 Common Stock 1191 8687 D Non-Qualified Stock Option (right to buy) 83.83 2017-07-20 4 M 0 4772 0.00 D 2026-07-14 Common Stock 4772 13723 D Non-Qualified Stock Option (right to buy) 95.76 2017-07-20 4 M 0 522 0.00 D 2023-01-06 Common Stock 522 8870 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Represents weighted average sale price. Actual sale prices ranged from $129.57 - $132.10. Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. This includes an 18,165 aggregate of shares of common stock issuable pursuant to previously reported restricted stock units that have not vested Beginning March 2, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Beginning July 15, 2016, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Beginning January 7, 2016, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years /s/ Steven Stein 2017-07-21